Autoantibody of interleukin-17A induced by recombinant Mycobacterium smegmatis attenuates airway inflammation in mice with neutrophilic asthma

References

• Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372(9643):1107–1119. Cited in: PMID: 18805339. doi:10.1016/S0140-6736(08)61452-X.
   PubMed Web of Science ®Google Scholar
• Barrett NA, Austen KF. Innate cells and T helper 2 cell immunity in airway inflammation. Immunity. 2009;31(3):425–437. doi:10.1016/j.immuni.2009.08.014. Cited in: PMID: 19766085.
   PubMed Web of Science ®Google Scholar
• Ingram JL, Kraft M. IL-13 in asthma and allergic disease: asthma phenotypes and targeted therapies. J Allergy Clin Immunol. 2012;130(4):829–842. doi:10.1016/j.jaci.2012.06.034. Cited in: PMID: 22951057.
   PubMed Web of Science ®Google Scholar
• Li J, Lin LH, Wang J, Peng X, Dai HR, Xiao H, Li F, Wang YP, Yang ZJ, Li L. Interleukin-4 and interleukin-13 pathway genetics affect disease susceptibility, serum immunoglobulin E levels, and gene expression in asthma. Ann Allergy Asthma Immunol. 2014;113(2):173–179.e1. doi:10.1016/j.anai.2014.05.004. Cited in: PMID: 24980391.
   PubMed Web of Science ®Google Scholar
• Zijlstra GJ, Ten Hacken NH, Hoffmann RF, van Oosterhout AJ, Heijink IH. Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells. Eur Respir J. 2012;39(2):439–445. doi:10.1183/09031936.00017911. Cited in: PMID: 21828034.
   PubMed Web of Science ®Google Scholar
• Agache I, Ciobanu C, Agache C, Anghel M. Increased serum IL-17 is an independent risk factor for severe asthma. Respir Med. 2010;104(8):1131–1137. Cited in: PMID: 20338742. doi:10.1016/j.rmed.2010.02.018.
   PubMed Web of Science ®Google Scholar
• Silverpil E, Lindén A. IL-17 in human asthma. Expert Rev Respir Med. 2012;6(2):173–186. doi:10.1586/ers.12.12. Cited in: PMID: 22455490.
   PubMed Web of Science ®Google Scholar
• Barczyk A, Pierzchala W, Sozañska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med. 2003;97(6):726–733. doi:10.1053/rmed.2003.1507. Cited in: PMID: 12814161.
   PubMed Web of Science ®Google Scholar
• Park SJ, Lee YC. Interleukin-17 regulation: an attractive therapeutic approach for asthma. Respir Res. 2010; 11:78. doi:10.1186/1465-9921-11-78. Cited in: PMID: 20565710.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan RK, Al Heialy S, Hamid Q. Role of IL-17 in asthma pathogenesis and its implications for the clinic. Expert Rev Respir Med. 2019;13(11):1057–1068. doi:10.1080/17476348.2019.1666002. Cited in: PMID: 31498708.
   PubMed Web of Science ®Google Scholar
• Chesné J, Braza F, Mahay G, Brouard S, Aronica M, Magnan A. IL-17 in severe asthma. Where do we stand? Am J Respir Crit Care Med. 2014;190(10):1094–1101. doi:10.1164/rccm.201405-0859PP. Cited in: PMID: 25162311.
   PubMed Web of Science ®Google Scholar
• Pelaia G, Vatrella A, Busceti MT, Gallelli L, Calabrese C, Terracciano R, Maselli R. Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma. Mediators Inflamm. 2015; 2015:879783. doi:10.1155/2015/879783. Cited in: PMID: 25878402.
   PubMed Web of Science ®Google Scholar
• Hastie AT, Moore WC, Meyers DA, Vestal PL, Li H, Peters SP, Bleecker ER, National Heart, Lung, and Blood Institute Severe Asthma Research Program. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol. 2010;125(5):1028–1036.e13. Cited in: PMID: 20398920. doi:10.1016/j.jaci.2010.02.008.
   PubMed Web of Science ®Google Scholar
• Chung KF. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies. J Intern Med. 2016;279(2):192–204. doi:10.1111/joim.12382. Cited in: PMID: 26076339.
   PubMed Web of Science ®Google Scholar
• Vazquez-Tello A, Halwani R, Hamid Q, Al-Muhsen S. Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells. J Clin Immunol. 2013;33(2):466–478. doi:10.1007/s10875-012-9828-3. Cited in: PMID: 23160983.
   PubMed Web of Science ®Google Scholar
• Keenan CR, Salem S, Fietz ER, Gualano RC, Stewart AG. Glucocorticoid-resistant asthma and novel anti-inflammatory drugs. Drug Discov Today. 2012;17(17-18):1031–1038. doi:10.1016/j.drudis.2012.05.011. Cited in: PMID: 22659097.
   PubMed Web of Science ®Google Scholar
• Al-Ramli W, Préfontaine D, Chouiali F, Martin JG, Olivenstein R, Lemière C, Hamid Q. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol. 2009;123(5):1185–1187. doi:10.1016/j.jaci.2009.02.024. Cited in: PMID: 19361847.
   PubMed Web of Science ®Google Scholar
• Lajoie S, Lewkowich IP, Suzuki Y, Clark JR, Sproles AA, Dienger K, Budelsky AL, Wills-Karp M. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol. 2010;11(10):928–935. doi:10.1038/ni.1926. Cited in: PMID: 20802484.
   PubMed Web of Science ®Google Scholar
• Lewis-Tuffin LJ, Cidlowski JA. The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann N Y Acad Sci. 2006; 1069:1–9. doi:10.1196/annals.1351.001. Cited in: PMID: 16855130.
   PubMed Web of Science ®Google Scholar
• Lindén A, Dahlén B. Interleukin-17 cytokine signalling in patients with asthma. Eur Respir J. 2014;44(5):1319–1331. doi:10.1183/09031936.00002314. Cited in: PMID: 24925921.
   PubMed Web of Science ®Google Scholar
• Chen L, Guo S, Wu L, Fan X, Ma H, Wu K, Wu J, Zhang J. IL-17A Autoantibody Induced by Recombinant Mycobacterium smegmatis Expressing Ag85A-IL-17A Fusion Protein. Appl Biochem Biotechnol. 2015;176(7):2018–2026. doi:10.1007/s12010-015-1697-9. Cited in: PMID: 26047929.
   PubMed Web of Science ®Google Scholar
• Xu W, Chen L, Guo S, Wu L, Zhang J. Intranasal administration of recombinant mycobacterium smegmatis inducing IL-17A autoantibody attenuates airway inflammation in a murine model of allergic asthma. PLoS One. 2016;11(3):e0151581. doi:10.1371/journal.pone.0151581. Cited in: PMID: 26974537.
   PubMed Web of Science ®Google Scholar
• Myou S, Leff AR, Myo S, Boetticher E, Tong J, Meliton AY, Liu J, Munoz NM, Zhu X. Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J Exp Med. 2003;198(10):1573–1582. doi:10.1084/jem.20030298. Cited in: PMID: 14623911.
   PubMed Web of Science ®Google Scholar
• Dong C, Wang G, Li B, Xiao K, Ma Z, Huang H, Wang X, Bai C. Anti-asthmatic agents alleviate pulmonary edema by upregulating AQP1 and AQP5 expression in the lungs of mice with OVA-induced asthma. Respir Physiol Neurobiol. 2012;181(1):21–28. doi:10.1016/j.resp.2011.12.008. Cited in: PMID: 22226856.
   PubMed Web of Science ®Google Scholar
• Onoue S, Misaka S, Aoki Y, Karaki S, Kuwahara A, Ohide A, Mizumoto T, Yamada S. Inhalable powder formulation of vasoactive intestinal peptide derivative, [R15,20,21, L17]-VIP-GRR, attenuated neutrophilic airway inflammation in cigarette smoke-exposed rats. Eur J Pharm Sci. 2010;41(3–4):508–514. doi:10.1016/j.ejps.2010.08.007. Cited in: PMID: 20797433.
   PubMed Web of Science ®Google Scholar
• Boyce JA, Bochner B, Finkelman FD, Rothenberg ME. Advances in mechanisms of asthma, allergy, and immunology in 2011. J Allergy Clin Immunol. 2012;129(2):335–341. doi:10.1016/j.jaci.2011.12.968. Cited in: PMID: 22284930.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest. 2008;118(11):3546–3556. doi:10.1172/JCI36130. Cited in: PMID: 18982161.
   PubMed Web of Science ®Google Scholar
• Manuyakorn W. Airway remodelling in asthma: role for mechanical forces. Asia Pac Allergy. 2014;4(1):19–24. doi:10.5415/apallergy.2014.4.1.19. Cited in: PMID: 24527406.
   PubMedGoogle Scholar
• Wang YH, Wills-Karp M. The potential role of interleukin-17 in severe asthma. Curr Allergy Asthma Rep. 2011;11(5):388–394. doi:10.1007/s11882-011-0210-y. Cited in: PMID: 21773747.
   PubMed Web of Science ®Google Scholar
• Durrant DM, Metzger DW. Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol Invest. 2010;39(4-5):526–549. doi:10.3109/08820131003615498. Cited in: PMID: 20450290.
   PubMed Web of Science ®Google Scholar
• Chakir J, Shannon J, Molet S, Fukakusa M, Elias J, Laviolette M, Boulet LP, Hamid Q. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol. 2003;111(6):1293–1298. Cited in: PMID: 12789232. doi:10.1067/mai.2003.1557.
   PubMed Web of Science ®Google Scholar
• Yang G, Li L, Volk A, Emmell E, Petley T, Giles-Komar J, Rafferty P, Lakshminarayanan M, Griswold DE, Bugelski PJ, et al. Therapeutic dosing with anti-interleukin-13 monoclonal antibody inhibits asthma progression in mice. J Pharmacol Exp Ther. 2005;313(1):8–15. doi:10.1124/jpet.104.076133. Cited in: PMID: 15644434.
   PubMed Web of Science ®Google Scholar
• Holgate ST, Chuchalin AG, Hebert J, Lotvall J, Persson GB, Chung KF, Bousquet J, Kerstjens HA, Fox H, Thirlwell J, on behalf of the Omalizumab 011 International Study Group, et al. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy. 2004;34(4):632–638. x. Cited in: PMID: 15080818. doi:10.1111/j.1365-2222.2004.1916.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ. New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease. Rev Gastroenterol Disord. 2005;5(1):10–18. Cited in: PMID: 15741928.
   PubMedGoogle Scholar
• Ma Y, Hayglass KT, Becker AB, Halayko AJ, Basu S, Simons FE, Peng Z. Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice. Allergy. 2007;62(6):675–682. doi: 10.1111/j.1398-9995.2007.01384.x. Cited in: PMID: 17508973.
   PubMed Web of Science ®Google Scholar
• Ma Y, HayGlass KT, Becker AB, Fan Y, Yang X, Basu S, Srinivasan G, Simons FE, Halayko AJ, Peng Z. Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice. Am J Respir Crit Care Med. 2007;176(5):439–445. doi:10.1164/rccm.200610-1405OC. Cited in: PMID: 17556715.
   PubMed Web of Science ®Google Scholar
• Wilder JA, Collie DD, Bice DE, Tesfaigzi Y, Lyons CR, Lipscomb MF. Ovalbumin aerosols induce airway hyperreactivity in naïve DO11.10 T cell receptor transgenic mice without pulmonary eosinophilia or OVA-specific antibody. J Leukoc Biol. 2001;69(4):538–547. Cited in: PMID: 11310839.
   PubMed Web of Science ®Google Scholar
• Laan M, Cui ZH, Hoshino H, Lötvall J, Sjöstrand M, Gruenert DC, Skoogh BE, Lindén A. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999;162(4):2347–2352. Cited in: PMID: 9973514.
   PubMed Web of Science ®Google Scholar
• Pelletier M, Maggi L, Micheletti A, Lazzeri E, Tamassia N, Costantini C, Cosmi L, Lunardi C, Annunziato F, Romagnani S, et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood. 2010;115(2):335–343. doi:10.1182/blood-2009-04-216085. Cited in: PMID: 19890092.
   PubMed Web of Science ®Google Scholar
• Nembrini C, Marsland BJ, Kopf M. IL-17-producing T cells in lung immunity and inflammation. J Allergy Clin Immunol. 2009;123(5):986–994. quiz 995-6. doi:10.1016/j.jaci.2009.03.033. Cited in: PMID: 19410688.
   PubMed Web of Science ®Google Scholar
• Ciepiela O, Ostafin M, Demkow U. Neutrophils in asthma-a review. Respir Physiol Neurobiol. 2015; 209:13–16. doi:10.1016/j.resp.2014.12.004. Cited in: PMID: 25511380.
   PubMed Web of Science ®Google Scholar
• Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA. The neutrophil as a cellular source of chemokines. Immunol Rev. 2000; 177:195–203. doi: 10.1034/j.1600-065x.2000.17706.x. Cited in: PMID: 11138776.
   PubMed Web of Science ®Google Scholar
• Song X, Qian Y. The activation and regulation of IL-17 receptor mediated signaling. Cytokine. 2013;62(2):175–182. doi:10.1016/j.cyto.2013.03.014. Cited in: PMID: 23557798.
   PubMed Web of Science ®Google Scholar
• McGeachy MJ, Chen Y, Tato CM, Laurence A, Joyce-Shaikh B, Blumenschein WM, McClanahan TK, O’Shea JJ, Cua DJ. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol. 2009;10(3):314–324. doi:10.1038/ni.1698. Cited in: PMID: 19182808.
   PubMed Web of Science ®Google Scholar
• Argollo MC, Allocca M, Furfaro F, Peyrin-Biroulet L, Danese S. Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease? Curr Pharm Des. 2019;25(1):25–31. doi:10.2174/1381612825666190313140811. Cited in: PMID: 31092171.
   PubMed Web of Science ®Google Scholar
• Zhu S, Qian Y. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Clin Sci (Lond). 2012;122(11):487–511. doi:10.1042/CS20110496.
   PubMed Web of Science ®Google Scholar
• Drost EM, MacNee W. Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. Eur J Immunol. 2002;32(2):393–403. Cited in: PMID: 11813158. doi:10.1002/1521-4141(200202)32:2 < 393::AID-IMMU393 > 3.0.CO;2-5.
   PubMed Web of Science ®Google Scholar
• Monteseirín J. Neutrophils and asthma. J Investig Allergol Clin Immunol. 2009;19:340–354. Cited in: PMID: 19862934.
   PubMed Web of Science ®Google Scholar
• Cowburn AS, Condliffe AM, Farahi N, Summers C, Chilvers ER. Advances in neutrophil biology: clinical implications. Chest. 2008;134(3):606–612. doi:10.1378/chest.08-0422. Cited in: PMID: 18779195.
   PubMed Web of Science ®Google Scholar
• Geerdink RJ, Pillay J, Meyaard L, Bont L. Neutrophils in respiratory syncytial virus infection: A target for asthma prevention. J Allergy Clin Immunol. 2015;136(4):838–847. doi:10.1016/j.jaci.2015.06.034. Cited in: PMID: 26277597.
   PubMed Web of Science ®Google Scholar